Systematic versus sentinel-lymph-node-driven axillary-lymph-node dissection in clinically node-negative patients with operable breast cancer. Results of the GF-GS01 randomized trial

PURPOSE: Sentinel-lymph-node (SLN) resection seems to minimize systematic axillary-lymph-node dissection (sALND) side effects in operated breast cancer patients. We explored whether SLN resection achieves similar therapeutic outcomes as sALND but with fewer side effects. METHODS: A randomized, contr...

Descripción completa

Detalles Bibliográficos
Autores principales: Roy, P., Leizorovicz, A., Villet, R., Mercier, C., Bobin, J. Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999168/
https://www.ncbi.nlm.nih.gov/pubmed/29526019
http://dx.doi.org/10.1007/s10549-018-4733-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999168/
https://www.ncbi.nlm.nih.gov/pubmed/29526019
http://dx.doi.org/10.1007/s10549-018-4733-y

Ejemplares similares